1. Home
  2. DMF vs CBUS Comparison

DMF vs CBUS Comparison

Compare DMF & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMF
  • CBUS
  • Stock Information
  • Founded
  • DMF 1988
  • CBUS 2010
  • Country
  • DMF United States
  • CBUS United States
  • Employees
  • DMF N/A
  • CBUS N/A
  • Industry
  • DMF Finance/Investors Services
  • CBUS Agricultural Chemicals
  • Sector
  • DMF Finance
  • CBUS Industrials
  • Exchange
  • DMF Nasdaq
  • CBUS Nasdaq
  • Market Cap
  • DMF 149.8M
  • CBUS 120.1M
  • IPO Year
  • DMF N/A
  • CBUS 2017
  • Fundamental
  • Price
  • DMF $7.20
  • CBUS $2.36
  • Analyst Decision
  • DMF
  • CBUS Strong Buy
  • Analyst Count
  • DMF 0
  • CBUS 3
  • Target Price
  • DMF N/A
  • CBUS $22.83
  • AVG Volume (30 Days)
  • DMF 60.7K
  • CBUS 238.4K
  • Earning Date
  • DMF 01-01-0001
  • CBUS 11-07-2024
  • Dividend Yield
  • DMF 2.66%
  • CBUS N/A
  • EPS Growth
  • DMF N/A
  • CBUS N/A
  • EPS
  • DMF 0.15
  • CBUS N/A
  • Revenue
  • DMF N/A
  • CBUS $4,152,999.00
  • Revenue This Year
  • DMF N/A
  • CBUS $132.42
  • Revenue Next Year
  • DMF N/A
  • CBUS $97.96
  • P/E Ratio
  • DMF $45.13
  • CBUS N/A
  • Revenue Growth
  • DMF N/A
  • CBUS 449.34
  • 52 Week Low
  • DMF $5.37
  • CBUS $2.17
  • 52 Week High
  • DMF $6.79
  • CBUS $23.18
  • Technical
  • Relative Strength Index (RSI)
  • DMF 54.31
  • CBUS 39.09
  • Support Level
  • DMF $7.07
  • CBUS $2.38
  • Resistance Level
  • DMF $7.18
  • CBUS $2.89
  • Average True Range (ATR)
  • DMF 0.08
  • CBUS 0.33
  • MACD
  • DMF 0.02
  • CBUS 0.03
  • Stochastic Oscillator
  • DMF 90.38
  • CBUS 27.51

About DMF BNY Mellon Municipal Income Inc.

BNY Mellon Municipal Income, Inc. is a non-diversified closed-end management investment company. Its investment objective is to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The fund invests in municipal obligations that are rated investment grade and have maturities of less than one year. The company targets to invest in the sector such as education, pre-refunded muni, utility, transportation, healthcare, special tax, state/territory general obligations, industry revenue, and pollution control.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: